Drug Search Results
More Filters [+]

NONOXYNOL-9

Alternative Names: nonoxynol-9, delfen
Latest Update: 2018-05-01
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Sperm Degrader

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Vaginal

FDA Designation: None *

Approval Status: Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: CONRAD
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for NONOXYNOL-9

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Communicable Diseases|HIV Infections|Deficiency Diseases|Acquired Immunodeficiency Syndrome

Phase 1: HIV Infections|Contraception

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

A13-126

P1

Completed

Contraception

2016-03-01

HIVNET 008

P1

Completed

HIV Infections

None

HIVNET 016 Pilot

P3

Completed

Communicable Diseases|HIV Infections|Deficiency Diseases|Acquired Immunodeficiency Syndrome

None

Recent News Events

Date

Type

Title